Literature DB >> 19125391

Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas.

Inas S Khayal1, Tracy R McKnight, Colleen McGue, Scott Vandenberg, Kathleen R Lamborn, Susan M Chang, Soonmee Cha, Sarah J Nelson.   

Abstract

Distinguishing between low-grade oligodendrogliomas (ODs) and astrocytomas (AC) is of interest for defining prognosis and stratifying patients to specific treatment regimens. The purpose of this study was to determine if the apparent diffusion coefficient (ADC) and fractional anisotropy (FA) from diffusion imaging can help to differentiate between newly diagnosed grade II OD and AC subtypes and to evaluate the ADC and FA values for the mixed population of oligoastrocytomas (OA). Fifty-three patients with newly diagnosed grade II gliomas were studied using a 1.5T whole body scanner (23 ODs, 16 ACs, and 14 OAs). The imaging protocol included post-gadolinium T1-weighted images, T2-weighted images, and either three and/or six directional diffusion imaging sequence with b = 1000 s/mm(2). Diffusion-weighted images were analyzed using in-house software to calculate maps of ADC and for six directional acquisitions, FA. The intensity values were normalized by values from normal appearing white matter (NAWM) to generate maps of normalized apparent diffusion coefficient (nADC) and normalized fractional anisotropy (nFA). The hyperintense region in the T2 weighted image was defined as the T2All region. A Mann-Whitney rank-sum test was performed on the 25th, median, and 75th nADC and nFA among the three subtypes. Logistic regression was performed to determine how well the nADC and nFA predict subtype. Lesions diagnosed as being OD had significantly lower nADC and significantly higher nFA, compared to AC. The nADC and nFA values individually classified the data with an accuracy of 87%. Combining the two did not enhance the classification. The patients with OA had nADC and nFA values between those of OD and AC. This suggests that ADC and FA may be helpful in directing tissue sampling to the most appropriate regions for taking biopsies in order to make a definitive diagnosis.

Entities:  

Mesh:

Year:  2009        PMID: 19125391      PMCID: PMC3772178          DOI: 10.1002/nbm.1357

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  29 in total

1.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.

Authors:  Y Zhang; M Brady; S Smith
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

2.  Echoplanar diffusion-weighted MRI with intravenous gadolinium-DTPA.

Authors:  C Fitzek; H J Mentzel; S Fitzek; D Sauner; W A Kaiser; J R Reichenbach
Journal:  Neuroradiology       Date:  2003-08-16       Impact factor: 2.804

3.  Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo.

Authors:  T L Chenevert; J A Brunberg; J G Pipe
Journal:  Radiology       Date:  1990-11       Impact factor: 11.105

4.  Intracranial oligodendrogliomas: imaging findings in 35 untreated cases.

Authors:  Y Y Lee; P Van Tassel
Journal:  AJR Am J Roentgenol       Date:  1989-02       Impact factor: 3.959

5.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders.

Authors:  D Le Bihan; E Breton; D Lallemand; P Grenier; E Cabanis; M Laval-Jeantet
Journal:  Radiology       Date:  1986-11       Impact factor: 11.105

6.  Pulsed NMR study of water mobility in muscle and brain tissue.

Authors:  J R Hansen
Journal:  Biochim Biophys Acta       Date:  1971

7.  The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.

Authors:  J Glass; F H Hochberg; M L Gruber; D N Louis; D Smith; B Rattner
Journal:  J Neurosurg       Date:  1992-05       Impact factor: 5.115

8.  Long-term outcome of low-grade oligodendroglioma and mixed glioma.

Authors:  J D Olson; E Riedel; L M DeAngelis
Journal:  Neurology       Date:  2000-04-11       Impact factor: 9.910

9.  Oligodendrogliomas: the Mayo Clinic experience.

Authors:  E G Shaw; B W Scheithauer; J R O'Fallon; H D Tazelaar; D H Davis
Journal:  J Neurosurg       Date:  1992-03       Impact factor: 5.115

10.  Oligodendrogliomas: CT patterns with emphasis on features indicating malignancy.

Authors:  D Vonofakos; H Marcu; H Hacker
Journal:  J Comput Assist Tomogr       Date:  1979-12       Impact factor: 1.826

View more
  15 in total

1.  Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps.

Authors:  Antonella Castellano; Marina Donativi; Roberta Rudà; Giorgio De Nunzio; Marco Riva; Antonella Iadanza; Luca Bertero; Matteo Rucco; Lorenzo Bello; Riccardo Soffietti; Andrea Falini
Journal:  Eur Radiol       Date:  2015-08-30       Impact factor: 5.315

2.  Differential kinetics of α-[¹¹C]methyl-L-tryptophan on PET in low-grade brain tumors.

Authors:  Csaba Juhász; Otto Muzik; Diane C Chugani; Harry T Chugani; Sandeep Sood; Pulak K Chakraborty; Geoffrey R Barger; Sandeep Mittal
Journal:  J Neurooncol       Date:  2010-07-30       Impact factor: 4.130

3.  MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas.

Authors:  Inas S Khayal; Scott R Vandenberg; Kenneth J Smith; Colleen P Cloyd; Susan M Chang; Soonmee Cha; Sarah J Nelson; Tracy R McKnight
Journal:  Neuro Oncol       Date:  2011-08-24       Impact factor: 12.300

4.  Interhemispheric Difference Images from Postoperative Diffusion Tensor Imaging of Gliomas.

Authors:  Robert Kosztyla; Stefan A Reinsberg; Vitali Moiseenko; Brian Toyota; Alan Nichol
Journal:  Cureus       Date:  2016-10-05

Review 5.  Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.

Authors:  Sarah J Nelson
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

6.  Non-stem cell origin for oligodendroglioma.

Authors:  Anders I Persson; Claudia Petritsch; Fredrik J Swartling; Melissa Itsara; Fraser J Sim; Romane Auvergne; David D Goldenberg; Scott R Vandenberg; Kim N Nguyen; Stanislava Yakovenko; Jennifer Ayers-Ringler; Akiko Nishiyama; William B Stallcup; Mitchel S Berger; Gabriele Bergers; Tracy R McKnight; Steven A Goldman; William A Weiss
Journal:  Cancer Cell       Date:  2010-12-14       Impact factor: 31.743

7.  Glioma grade assessment by using histogram analysis of diffusion tensor imaging-derived maps.

Authors:  András Jakab; Péter Molnár; Miklós Emri; Ervin Berényi
Journal:  Neuroradiology       Date:  2010-09-21       Impact factor: 2.804

8.  Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging.

Authors:  Wei Bian; Inas S Khayal; Janine M Lupo; Colleen McGue; Scott Vandenberg; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Sarah J Nelson
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

9.  American Association for Cancer Research Genetics and Biology of Brain Cancers 2009, December 13-15, 2009, San Diego, CA.

Authors:  Isaac Yang; Linda M Liau
Journal:  J Neurooncol       Date:  2010-09       Impact factor: 4.130

10.  Differentiation of Low- and High-Grade Gliomas Using High b-Value Diffusion Imaging with a Non-Gaussian Diffusion Model.

Authors:  Y Sui; Y Xiong; J Jiang; M M Karaman; K L Xie; W Zhu; X J Zhou
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-02       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.